The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.

[1]  E. Mutius.  Of attraction and rejection--asthma and the microbial world. , 2007 .

[2]  Hans Bisgaard,et al.  Childhood asthma after bacterial colonization of the airway in neonates. , 2007, The New England journal of medicine.

[3]  S. Guerra,et al.  Low IFN-γ production in the first year of life as a predictor of wheeze during childhood , 2007 .

[4]  S. Johnston.  Innate immunity in the pathogenesis of virus-induced asthma exacerbations. , 2007, Proceedings of the American Thoracic Society.

[5]  D. Strachan,et al.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys , 2006, The Lancet.

[6]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[7]  Vernon M Chinchilli,et al.  Long-term inhaled corticosteroids in preschool children at high risk for asthma. , 2006, The New England journal of medicine.

[8]  U. Schaad.  Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85 , 2005, European Respiratory Review.

[9]  J. Weiser,et al.  Host and Bacterial Factors Contributing to the Clearance of Colonization by Streptococcus pneumoniae in a Murine Model , 2005, Infection and Immunity.

[10]  S. H. Arshad.  Primary prevention of asthma and allergy. , 2005, The Journal of allergy and clinical immunology.

[11]  W. Bessler,et al.  Th1-orientated immunological properties of the bacterial extract OM-85-BV. , 2005, European journal of medical research.

[12]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[13]  H. Bisgaard,et al.  Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. , 2005, American journal of respiratory and critical care medicine.

[14]  R. Gangnon,et al.  Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. , 2004, American journal of respiratory and critical care medicine.

[15]  I. Doull.  Limitations of maintenance therapy for viral respiratory infection-induced asthma. , 2003, The Journal of pediatrics.

[16]  M. Weinberger.  Treatment strategies for viral respiratory infection-induced asthma. , 2003, The Journal of pediatrics.

[17]  U. Schaad,et al.  Clinical Investigations: CoughImmunostimulation with OM-85 in Children with Recurrent Infections of the Upper Respiratory Tract: A Double-Blind, Placebo-Controlled Multicenter Study , 2002 .

[18]  N. Papadopoulos,et al.  A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.

[19]  S. Johnston,et al.  Viruses in asthma , 2002, British medical bulletin.

[20]  F. Martinez,et al.  Development of wheezing disorders and asthma in preschool children. , 2002, Pediatrics.

[21]  C. Kuehni,et al.  Are all wheezing disorders in very young (preschool) children increasing in prevalence? , 2001, The Lancet.

[22]  A. Berber,et al.  Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. , 2001, Chest.

[23]  M. Roth,et al.  Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines , 2000, Thorax.

[24]  A. Berber,et al.  Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. , 2000, Clinical therapeutics.

[25]  F. Ducharme,et al.  Inhaled steroids for episodic viral wheeze of childhood. , 2000, The Cochrane database of systematic reviews.

[26]  J. Svedmyr,et al.  Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers , 1999, Acta paediatrica.

[27]  M. Goldman,et al.  Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cells. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[28]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[29]  M. Silverman,et al.  Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. , 1995, Archives of disease in childhood.

[30]  M. Kramer,et al.  Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group. , 1993, The Pediatric infectious disease journal.

[31]  C. Donner,et al.  Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. , 1993, Chest.

[32]  W. Lenney,et al.  Prevention of viral induced asthma attacks using inhaled budesonide. , 1993, Archives of disease in childhood.

[33]  R. Gangnon,et al.  Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. , 2006, The Journal of allergy and clinical immunology.

[34]  C. de la Torre,et al.  [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children]. , 1998, Allergologia et immunopathologia.

[35]  J. Mauël.  Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. , 1994, Respiration; international review of thoracic diseases.

[36]  J. Paupe.  Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. , 1991, Respiration; international review of thoracic diseases.

[37]  M. Hallek,et al.  Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. , 1990, Respiration; international review of thoracic diseases.

[38]  B. Čvoriščec,et al.  Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. , 1989, Respiration; international review of thoracic diseases.

[39]  O. Djuric,et al.  Effect of broncho-vaxom on clinical and immunological parameters in patients with chronic obstructive bronchitis. A double-blind, placebo-controlled study , 1989 .

[40]  G. Losa,et al.  Clinical and immunobiological effects of an orally administered bacterial extract. , 1984, International journal of immunopharmacology.

[41]  J. Torroella,et al.  Immunoglobulin production in man stimulated by an orally administered bacterial lysate. , 1980, Respiration; international review of thoracic diseases.